Impact of Chlorhexidine Cleansing on Bacteria Colonizing the Umbilical Cord of Infants in Bangladesh

NCT ID: NCT00719329

Last Updated: 2012-04-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1931 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-08-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: In developing countries, many babies are born at home and the umbilical cord commonly becomes infected during the first week after birth, and can be deadly. Cleansing of the cord with a low-cost antiseptic like chlorhexidine may reduce the risk of these infections. Little is known, however, about the frequency of chlorhexidine cleansing needed to impact upon the overall presence of bacteria on the stump, or regarding the changes in bacteria during the first week of life when most cord infections occur.

Objectives: We will describe the profile of bacteria colonizing the umbilical cord stump of infants in rural Bangladesh and examine the role of topical chlorhexidine in altering colonization and progress of infection. We will compare the overall and bacteria-specific rate of colonization of the cord stump between infants receiving chlorhexidine cleansing of their cord through the first day or first week of life. We will also quantify the relationship between colonization of the cord stump with specific pathogens and the presence and severity of signs of umbilical cord infection (pus, redness, swelling) among these newborns.

Potential Impact: More information is needed on the impact of single versus repeated applications of chlorhexidine to the cord stump, as the number of cleansing may substantially influence the feasibility of widespread scale-up in many populations. The data generated from this proposed study will guide the most appropriate design of this simple intervention and will help inform specific treatment protocols for effective management of infants with signs of umbilical cord infections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Chlorhexidine cleansing of the cord for seven days

Group Type EXPERIMENTAL

Chlorhexidine 4.0%

Intervention Type DRUG

Solution (4.0%, 7.1% CHX-D)

B

Chlorhexidine cleansing of the cord for 1 day

Group Type EXPERIMENTAL

Chlorhexidine 4.0%

Intervention Type DRUG

Solution (4.0%, 7.1% CHX-D)

C

Dry cord care, as recommended by WHO

Group Type PLACEBO_COMPARATOR

Dry Cord Care

Intervention Type BEHAVIORAL

Educational messages regarding clean cord care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chlorhexidine 4.0%

Solution (4.0%, 7.1% CHX-D)

Intervention Type DRUG

Dry Cord Care

Educational messages regarding clean cord care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Enrolled in parent chlorhexidine cleansing trial

Exclusion Criteria

* Not enrolled in parent trial
* First visited after 48 hours of life
Maximum Eligible Age

7 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dhaka Shishu Hospital

OTHER

Sponsor Role collaborator

Shimantik, Bangladesh

UNKNOWN

Sponsor Role collaborator

Thrasher Research Fund

OTHER

Sponsor Role collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luke C. Mullany

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luke C Mullany, PhD

Role: STUDY_DIRECTOR

Johns Hopkins Bloomberg School of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Johns Hopkins Bloomberg School of Public Health

Baltimore, Maryland, United States

Site Status

Projahnmo

Sylhet, Sylhet Division, Bangladesh

Site Status

Dhaka Shishu Hospital

Dhaka, , Bangladesh

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Bangladesh

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

THRASHER-02827-0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.